CAS: 14618-80-5; (R)-2-((Benzyloxy)Methyl)Oxirane

相似化合物

16495-13-9 2930-05-4 57044-25-4

上下游产品

CAS号2930-05-4 苄基缩水甘油醚 | CAS号56552-80-8 (R)-(+)-1-苄基丙三醇 | CAS号16495-04-8 (S)-(+)-1-苄氧基-3... | CAS号100-39-0 溴化苄 | CAS号60456-23-7 (S)-缩水甘油 | CAS号14719-32-5 1-benzyloxy-3-i... | CAS号14593-43-2 烯丙基苄基醚 | CAS号17325-85-8 (S)-(-)-3-苄氧基-1... | CAS号2156-73-2 (1-chloro-2-met... | CAS号205242-64-4 (S)-1-(苄基氨基)-3-... | CAS号205242-66-6 (S)-4-苄基-2-((苄氧... | CAS号14347-78-5 (R)-(-)-甘油醇缩丙酮 | CAS号167354-12-3 (2R)-1-phenylme... | CAS号1240786-75-7 (R)-2-(Benzylox...

烯丙基苄基醚置于间氯过氧苯甲酸体系中,用 乙醇 用作溶剂,化学反应 2.0H,以82%的收率获得(R)-苄氧甲基环氧乙烷
参考文献:使用脂质体化的间氯过苯甲酸(lip Mcpba)进行对映选择性环氧化
标题:使用脂质体化的间氯过苯甲酸(lip Mcpba)进行对映选择性环氧化
摘要:已经证明使用脂质体化形式的间氯过苯甲酸(lip Mcpba)对官能化和未官能化的烯烃进行高度对映选择性环氧化.
Doi:10.1016/0040-4039(96)00925-2

专利信息

专利号:US-9475757-B2
优先权日:2013-05-03
标 题 :Synthesis of anti-Parkinson agent
发明人：MUTHUKRISHNAN MURUGAN; MUJAHID MOHAMMAD
权利人:COUNCIL SCIENT IND RES
摘要:The present invention relates to an improved process for synthesis of anti-Parkinson compound of formula (I) from commercially available (R)-benzyl glycidyl ether, wherein the compound obtained has enantiopurity greater than >98%. Formula (I) wherein R 1 and R 2 are each independently selected from hydrogen or halogen.

专利号:US-9284306-B2
优先权日:2012-05-11
标题 :(R)-Nifuratel, its use for the treatment of infections and synthesis of (R) and (S)-Nifuratel
发明人：GAGLIARDI STEFANIA; CONSONNI ALESSANDRA; MAILLAND FEDERICO; BULGHERONI ANNA
权利人:POLICHEM SA
摘要:(R)-Nifuratel is disclosed together with its use as bactericide and bacteriostatic agent as well as the pharmaceutical compositions containing the same; (R)-nifuratel has been surprisingly found to possess a better antimicrobial profile than either nifuratel racemate or (S)-nifuratel. A new procedure for the synthesis of both (R)-Nifuratel and (S)-Nifuratel is also disclosed.

专利号:US-5591852-A
优先权日:1990-08-10
标题 :Process for the preparation of nucleotides
发明人：VEMISHETTI PURUSHOTHAM; BRODFUEHRER PAUL R; HOWELL HENRY G; SAPINO JR CHESTER
权利人:ACAD OF SCIENCE CZECH REPUBLIC; REGA STICHTING
摘要:The present invention relates to a novel and economical process for the synthesis of HPMP-substituted nucleotide antiviral compounds. Also disclosed are novel intermediates produced in the process for the preparation of HPMPC.

专利号:US-7439364-B2
优先权日:2001-05-17
标 题 :Process for the synthesis of derivatives of halo-[2,3-F] quinoline
发明人：CHAN ANITA W; CURRAN TIMOTHY T; IERA SILVIO; CHEW WARREN; SELLSTEDT JOHN H; VID GALINA; FEIGELSON GREG; DING ZHIXIAN
权利人:WYETH CORP
摘要:Methods of preparing compounds of Formula I n nare provided.

专利号:US-8487108-B2
优先权日:2005-11-14
标题 :Piperidinyl carbamate intermediates for the synthesis of aspartic protease inhibitors
发明人：BALDWIN JOHN J; CLAREMON DAVID A; TICE COLIN; CACATIAN SALVACION; DILLARD LAWRENCE W; ISHCHENKO ALEXEY V; YUAN JING; XU ZHENRONG; MCGEEHAN GERARD; SIMPSON ROBERT D; SINGH SURESH B; ZHAO WEI; FLAHERTY PATRICK T
权利人:BALDWIN JOHN J; CLAREMON DAVID A; TICE COLIN; CACATIAN SALVACION; DILLARD LAWRENCE W; ISHCHENKO ALEXEY V; YUAN JING; XU ZHENRONG; MCGEEHAN GERARD; SIMPSON ROBERT D; SINGH SURESH B; ZHAO WEI; FLAHERTY PATRICK T; VITAE PHARMACEUTICALS INC
摘要:The present invention is directed to aspartic protease inhibitors. Certain aspartic protease inhibitors of the invention can be represented by the following structural formula or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors.

专利号:US-6417374-B1
优先权日:2001-02-15
标题 :Process for the preparation of beta hydroxy-delta lactone using novel intermediates
发明人：GHORPADE SANDEEP RAGHUNATH; KALKOTE UTTAM RAMRAO; CHAVAN SUBHASH PRATAPRAO; BHIDE SUNIL RAMCHANDRA; RAVINDRANATHAN THOTTAPPILLIL
权利人:COUNCIL SCIENT IND RES
摘要:The present invention relates to a process for the preparation of optically active 6-hydroxymethyl-4-(tert-butyldimethylsilyloxy)-(4R,6S)-tetrahydro-2H-2-pyranone(β-Hydroxy-δ-lactone) an important intermediate in the synthesis of biologically active drugs e.g. compactin, atorvastatin, fluvastatin, cholesterol lowering drugs.